HOOKIPA Pharma Inc. (HOOK)
Symbol Info
Listed Symbol HOOK
Name HOOKIPA Pharma Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $7,629,000
Latest Fiscal EPS $-0.99
Price Info
21 Day Moving Average $7.3662
21 Day EMA $7.412740
50 Day Moving Average $7.5594
50 Day EMA $7.672790
200 Day EMA $-
200 Day Moving Average -
52 Week High $14.76
52 Week Low $6.06
52 Week Change $
Alpha -0.064559
Beta 0.8610
Standard Deviation 0.213923
R2 0.031831
Periods 6
Share Information
10 Day Average Volume 18,961
20 Day Average Volume 18,779
30 Day Average Volume 18,356
50 Day Average Volume 26,225
Outstanding Shares 25,408,488
Float Shares 25,214,132
Percent Float 99.24%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 65
Institute Holdings Date 2019-09-30
Institute Bought Previous 3 Months 54,404
Institute Holdings Percent 26.100000
Institute Sold Previous 3 Months 108
Insider Holdings Date 2019-08-31
Insider Bought Previous 3 Months -
Insider Holdings Percent 0.80%
Insider Sold Previous 3 Months -
Insiders Shares Owned 194,356
Price Change
7 Day Price Change $1.6500006
7 Day Percent Change 24.92%
21 Day Price Change $0.7400003
21 Day Percent Change 9.83%
30 Day Price Change $0.2700005
30 Day Percent Change 3.38%
Month To Date Price Change $0.7700
Month To Date Percent 10.27%
90 Day Price Change $1.110001
90 Day Percent Change 15.50%
Quarter To Date $0.770000
Quarter To Date Percent 10.27%
180 Day Price Change $-5.73
180 Day Percent Change -40.93%
200 Day Price Change $-
200 Day Percent Change -
Year To Date $-
Year To Date Percent -
Profile
Description HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.
Details
Issue Type CS
Market Cap $210,128,196
Sec Type
Auditor PwC Wirtschaftsprüfung GmbH
Total Shares Outstanding 25,408,488
CEO Jorn Aldag
Employees 78
Last Audit UE
Classification
CIK 0001760542
Industry Biotechnology
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 350 Fifth Avenue
72nd Floor
New York, NY 10118
Website http://www.hookipapharma.com
Facisimile
Telephone +1 431 890-6360
Email
Key Ratios
Profitability
EBIT Margin -198.5
EBITDA Margin -185.3
Pre-Tax Profit Margin -
Profit Margin Cont -
Gross Margin -
Profit Margin TOT -
Income Statements
Revenue $13,266,000
Revenue Per Share $0.6145
Revenue 3 Years $-
Revenue 5 Years $-
Valuation Measures
PE Ratio -
Enterprise Value $68,534,660
Price To Sales 13.458392
Price To Free Cash -4.7
PE High Last 5 Years -
Price To Book 1.3
Price To Cash Flow -
PE Low Last 5 Years -
Price To Tangible Book 1.3
Financial Strength
Total Debt To Equity 0.1
Int Coverage -32.2
Current Ratio 8.7
Leverage Ratio 3.1
Quick Ratio 7.9
Long Term Debt To Capital 0.07
Assets
Receivables Turnover 2.7
Invoice Turnover -
Assets Turnover 0.10
Management Effectiveness
Return Assets -16.21
Return On Equity -20.03
Return On Capital -17.75
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
HOOK
HOOKIPA Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.